13th CONGRESS OF THE EADO

Information Program Now! Offline schedule (pdf) Conference Services Facebook Twitter

Information

 

WiFi Network : EADO2017

No Password needed

------------------------------------------------------

Mobile App

 The App is operating online via internet connection, no personal data required.

------------------------------------------------------

EADO CONNECTS YOU!

Looking for a friend who might be attending the congress? Use the #EADO2017 hashtag in all your congress-related social media posts on twitter and facebook and make sure you stay tuned and connected!

------------------------------------------------------

EMERGENCY CONTACTS

Registration - Accommodation : Spiros Lianos +30 694 804 3517

Faculty : Maria Milonaki +30 695 602 2306

Scientific Program: Pinelopi Mitroyianni +306948043520

Exhibition: Lydia Papaevangelou +30 694 700 8044

 


INDUSTRY SATELLITE LECTURE 1 - Supported by TAKEDA

Wednesday, May 3, 2017

N. SKALKOTAS HALL

14:30-15:00 | INDUSTRY SATELLITE LECTURE 1: The ALCANZA trial – A new dawn in the treatment of relapsed/refractory CTCL

 

14:30-14:35 | Rudolf Stadler: Welcome and introduction

14:35-14:50 | Rudolf Stadler: The ALCANZA trial – Treatment of relapsed/refractory CTCL with brentuximab vedotin

14:50-14:59 | Rudolf Stadler: Interrogating the ALCANZA data – What does it mean for patients and the CTCLtreatment paradigm?

14:59-15:00 | Rudolf Stadler: Closing remarks

 

Supported by  

INDUSTRY SATELLITE SYMPOSIUM 1 - Supported by INCYTE

Wednesday, May 3, 2017

MC 2 HALL

14:30-15:30 | INDUSTRY SATELLITE SYMPOSIUM 1 : Understanding the melanoma microenvironment

Chair: Alexander Eggermont

 

14:30-14:35 | Alexander Eggermont: Welcome and introductions

14:35-14:55 | Axel Hauschild: Treatment combinations in melanoma: Where are we now and where are we going?

14:55-15:15 | Michele Maio: The tumor microenvironment: Beyond the T cell

15:15-15:30 | All Faculty: Panel discussion, Q&A and closing remarks

   

Supported by

INDUSTRY SATELLITE LECTURE 2 - Supported by AMGEN

Wednesday, May 3, 2017

BANQUET HALL

17:30-18:00 |INDUSTRY SATELLITE LECTURE 2

Chair: Axel Hauschild

 

Ralf Gutzmer: What do oncolytic immunotherapies mean for patients with early metastatic melanoma?

 

Supported by 

INDUSTRY SATELLITE LECTURE 3 - Supported by NOVARTIS

Wednesday, May 3, 2017 

N. SKALKOTAS HALL

17:30-18:00 |INDUSTRY SATELLITE LECTURE 3

Chair: Helen Gogas

 

Ioannis Boukovinas: Individualized treatment strategy in melanoma

 

Supported by

INDUSTRY SATELLITE LUNCH SYMPOSIUM 2 - Supported by BRISTOL-MYERS SQUIBB

Thursday, May 4, 2017

BANQUET HALL

12:45-13:45 |INDUSTRY SATELLITE LUNCH SYMPOSIUM 2: Melanoma 2017: Update in Immuno-Oncology

Chair: Dimitris Bafaloukos

 

12:45-12:50 | Dimitrios Bafaloukos: Welcome and introduction

12:50-13:05 | Helen Gogas: Adjuvant therapy: Where are we today?

13:05-13:30 | Michael Postow: Considerations in clinical practice in metastatic melanoma

13:30-13:45 | Faculty panel: Hot topic debate

13:45 | Dimitris Bafaloukos: Summary and close

 

Supported by

INDUSTRY SATELLITE SYMPOSIUM 3 - Supported by MSD

Thursday, May 4, 2017

BANQUET HALL

15:30-16:30| INDUSTRY SATELLITE SYMPOSIUM 3: The evolution of melanoma management: Where to from here?

Chair: Alexander J. Stratigos

 

15:30-15:40 | Alexander J. Stratigos: Welcome and introduction

15:40-16:00 | Reinhard Dummer: Evolution of the science and the melanoma treatment landscape

16:00-16:20 | Helen Gogas: Optimising treatment selection: When, with what and in whom?

16:20-16:30 | Discussion and Q&A

 

Supported by

INDUSTRY SATELLITE SYMPOSIUM 4 - Supported by MERCK PFIZER Alliance

Thursday, May 4, 2017

N. SKALKOTAS HALL

18:30-19:30 | INDUSTRY SATELLITE SYMPOSIUM 4: Immuno-intervention in patients with Merkel cell carcinoma

Chair: Dirk Schadendorf

 

18:30-18:40 | Dirk Schadendorf: Welcome and introduction

18:40-18:55 | Paul Nghiem: Rationale for immuno-intervention in Merkel cell carcinoma

18:55-19:20 | Caroline Robert: Treatment approaches for Merkel cell carcinoma

19:20-19:30 | Dirk Schadendorf: Q&A – Closing comments

 

Supported by 

INDUSTRY SATELLITE LUNCH SYMPOSIUM 5 - Supported by ROCHE

Friday, May 5, 2017

BANQUET HALL

12:45-13:45 | INDUSTRY SATELLITE LUNCH SYMPOSIUM 5: Shaping the future together: Treatment of metastatic melanoma

Chair: Georgina V. Long

 

12:45-12:55 | Georgina Long: What does the future look like for patients with metastatic melanoma?

12:55-13:05 | Peter Mohr: Combining targeted therapy with immunotherapy: A rational approach

13:05-13:15 | Paolo Ascierto: Targeted therapy and immunotherapy, a potential

combination for the future: The early clinical evidence

13:15-13:45 | Helen Gogas, Peter Mohr, Paolo Ascierto: Achieving the best outcomes in metastatic melanoma today: The experts’ experience

Facilitated by Georgina Long

 

Supported by 

INDUSTRY SATELLITE SYMPOSIUM 6 - Supported by LEO PHARMA

Friday, May 5, 2017

MC 2 HALL

15:30-16:30 | INDUSTRY SATELLITE SYMPOSIUM 6

Chairs: Eggert Stockfleth - John Lear

 

Eggert Stockfleth & John Lear: Optimising actinic keratosis diagnosis and management: The scale of the problem

 

Supported by 

FLOOR PLAN